© 2024 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement
<< Back To Article
Hepatitis C: Treating Those at High Risk

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

Kathy Idoine

If highest risk includes those of us with transplants, why is this group being disregarded from the studies and consideration for approval of the drugs by pharmaceutical companies?

October 9, 2014 • Santa Cruz

Advertisement

Hot topics

Forums: Support and discussion
Blogs: The community speaks
Hep Stories: Get inspired
Magazine: Search the archives
#Coffee
A smiling Caucasian couple
#BabyBoomers

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.